论文部分内容阅读
在中国生物膜技术的舞台上,蓝伟光博士显然是最优秀的首席魔术师,他的高超技艺已经在国内外生物膜技术与用膜市场上广为人知。 他除了把一家创建时仅有3人的小公司在数年内就发展到上百人的股份公司,更重要的是,在2001年中国生物膜技术市场20个亿的份额中,蓝伟光所创建并领导的三达公司就做到了2亿多,占10％。而在过去的5年多时间里,三达在山东鲁抗,成功开发了利用膜技术生产大观霉素(淋必治)的新型生产工艺,使大观霉素提炼收率从原来的30％提高到85％;在江山制药,成功地开发膜法维C生产工艺,使江山制药一跃成
Biofilm technology in China on the stage, Dr. Weiguang Lan is clearly the best chief magician, his superb artistry has been widely known at home and abroad membrane technology and membrane market. In addition to building a small company with just three people in a few years he developed to hundreds of joint-stock companies, more importantly, in 2001 China's biofilm technology market share of 20 billion, Blue Weiguang created And led the Sanda companies have done more than 200 million, accounting for 10%. In the past five years or so, Sanda successfully developed a new production process for producing spectinomycin (DPC) using membrane technology in Lukang, Shandong Province, resulting in an increase in the yield of spectinomycin from 30% To 85%; Jiangshan Pharmaceutical, the successful development of membrane Faye C production technology, so that Jiangshan Pharmaceutical leapt into